Skip to content

Latest commit

 

History

History

cov

PoSeiDon: A small SARS-CoV-2 example based on the spike protein

PoSeiDon logo

Twitter Follow

Background

The following example is based on a recent publication of Zhou et al. 2020 about a novel bat Coronavirus closely related to SARS-CoV-2. The coding sequences of the spike protein used here were selected from GISAID and kindly provided by Bálint Mészáros (Thanks!).

This example will illustrate how PoSeiDon can be used to generate an in-frame alignment from a set of protein-coding sequences and check the alignment for possible recombination events and positively selected sites. We will briefly compare the output of PoSeiDon with results shown in Zhou et al. 2020, in particular, we will compare the HTML output of PoSeiDon with the alignment and important amino acide sites shown in Figure 2G and H in the mentioned publication.

Disclaimer: Using PoSeiDon, here, we only performed a recombination and positive slection analysis based on eight sequences out of the nine shown in Figure 2. Please keep in mind, that a sample size of eight is low for such an analysis and thus the statistical support of reported positively selected sites is low. Below, we will discuss some interesting sites that are in line with previously reported sites for SARS-CoV-2, however, they are not reported as significant (posterior probabilities are always < 0.95; PP) by PoSeiDon. The selection of input sequences always has a strong impact on such an evolutionary analysis and a balanced set of 15-20 sequences would likely result in way better PPs. Nevertheless, this small example shows the output of PoSeiDon in comparison to the results of Zhou et al. 2020. The authors did not perform a positive selection analysis, however, they discuss important sites in the spike protein of different Coronaviruses that were also previously characterized.

Data

The FASTA file contains eight Coronavirus sequences of the gene encoding the spike protein:

  • >SARS-CoV-2|GISAID:EPI_ISL_402124
  • >RmYN02|GISAID:EPI_ISL_412977
  • >RaTG13|GISAID:EPI_ISL_402131
  • >ZC45|NCBI:MG772933
  • >ZXC21|NCBI:MG772934
  • >pangolin/GX/P5L/2017|GISAID:EPI_ISL_410540
  • >GZ02|NCBI:AY390556
  • >SARS-CoV|GenBank:AY278741

To the best of our knowledge, the sequences correspond to the sequences shown in Figure 2 (Zhou et al. 2020). However, we were not able to extract all identical sequences from GISAID used in the publication. (again, thanks to Bálint Mészáros for providing this data for testing!). Nevertheless, there is a huge overlap and the results are in some cases in line with already known positively selected positions - although the sample size is still low.

Attention! The sequences in the FASTA file were already aligned with VIRULIGN, however, PoSeiDon performs its own in-frame alignment and thus gap symbols in sequences are simply ignored. Thus, some of the few differences between the PoSeiDon output and Figure 2 (mainly in the indices of codons in the alignment) come from differences in gapped regions of the alignments. For example, position 451 in Figure 2G corresponds to position 461 in the PoSeiDon output (see below).

Execution

We run PoSeiDon in version bb48dce7 with the following command:

nextflow run poseidon.nf --fasta Spike_ali_nucl-VIRULIGN.fasta --cores 8

The full output can be downloaded or directly investigated in the browser.

Results

Recombination

PoSeiDon (using GARD) detected many potential breakpoints and one with actual topological incongruence (2526; based on the alignment w/o gaps that GARD uses for testing). This breakpoint was reported as significant (and is therefore considered by PoSeiDon in the downstream analysis).

GARD

In this example, only significant breakpoints were considered, however, in a previous study, we found that taking also in-significant breakpoints into account can help to detect additional interesting sites potentially positively selected. However, such sites should be investigated with caution. Using the --kh parameter PoSeiDon will also analyze fragments based on in-significant breakpoints.

Positive selection

PoSeidon performs positive selection detection using CODEML on the full alignment and potential fragments based on detected recombination events (breakpoints) with GARD. Recombination events can have a large impact on the positive selection detection.

In the following, we will discuss the few positions identified as positively selected (with very weak posterior probability support, mainly due to low sample size) that are also marked in Figure 2G and H. The same alignment part that is shown in Figure 2G starting from alignment position 451 (Zhou et al. 2020) is shown below in the PoSeiDon output starting on position 461 (due to differences in the alignment):

Alignment full

Again, please keep in mind that no positive selection tests are significant for this small example. However, there are few sites with weak support for positive selection (493, 494, 503, 504, and 511). When looking at the same position in the fragment:

Alignment fragment

there are similar (weakly) positively selected sites: 493, 494, 503, 504, and 508. Actually, position 508 (corresponds to 498 in the Figure 2G) is found with one of the best supports for positive selection. The position seems to be not known to be of importance in the spike protein, however, it is found with low evidence by PoSeiDon.

Positions 503 and 504 (corresponding to marked positions 493 and 494 in Figure 2) have very week support but, at least, are identified as potentially positively selected by the pipeline.

Previous studies already showed "Six amino acid residues at the RBD (L455, F486, Q493, S494, N501, and Y505) have been reported to be major determinants of efficient receptor binding of SARS-CoV-2 to ACE2" (Zhou et al. 2020). Due to differences in the alignment these positions can not directly found in the PoSeiDon output but correspond to:

  • L455 = L465 --> no hit in PoSeiDon
  • F486 = F496 --> no hit in PoSeiDon
  • Q493 = Q503 --> low support in full aln and fragment 1
  • S494 = S504 --> low support in full aln and fragment 1
  • N501 = N511 --> low support in full aln
  • Y505 = Y515 --> no hit in PoSeiDon

In summary, only based on the eight coding sequences for the spike protein, PoSeiDon detected three out of the six previously reported positions to be positively selected (although with very low support due to sample size) and an additional position (508), that was only found based on the initial recombination detection and splitting of the alignment.

Zhou et al. 2020 also described a polybasic cleavage site in a region of O-linked glycan residues (see Figure 2H starting from alignment position 667). PoSeiDon aligned the same region correctly (starting from position 677):

Polybasic alignment part

The PPRA part is also aligned similar to Figure 2H. In addition, PoSeiDon detected one (very weak) positively selected site at 687 that should correspond to 677 in the manuscript figure. The same site has weak support in the full alignment. In addition position 699 has weak positive selection support in the full aln.

Conclusion

In summary, this small example illustrates the application of PoSeiDon for the detection of recombination events and positive selection in protein-coding sequences. Although the sample size (n=8) is too low to perform a sophisticated evolutionary analysis, PoSeiDon was still able to detect weak positive selection support of amino acid sites in the spike protein, that were previously reported based on larger data sets. In addition, the detection of a significant recombination event in the spike protein resulted in another putatively positively selected site (508 in fragment 1) that should be investigated in more detail.

Acknowledgement

I would like to thank the authors of Zhou et al. 2020 and in particular Bálint Mészáros for patiently testing PoSeiDon and for providing the selected spike coding sequences.

Citation

If PoSeiDon helps you please cite:

Martin Hölzer and Manja Marz, "PoSeiDon: a Nextflow pipeline for the detection of evolutionary recombination events and positive selection", BioRxiv (2020)